Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Vemlidy(r) Demonstrates Continued Efficacy and Improved Safety for Asian Patients with Hepatitis B 2021-02-04 12:00
FDA Approves TEPMETKO® as the First and Only Once-daily Oral MET Inhibitor for Patients with Metastatic NSCLC with METex14 Skipping Alterations 2021-02-04 02:57
Eucure Biopharma Announces Encouraging Antitumor Activity of Its anti-CD40 Antibody in PD-1 Refractory Ocular Melanoma when Combined with Junshi Biosciences' Toripalimab 2021-02-03 23:45
More Patients Set to Benefit as Kanghong Pharmaceutical Targets New Indications with Conbercept 2021-02-03 22:00
Longevity Acquisition Corporation Announces 4D pharma Update on Oncology Program 2021-02-03 22:00
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Pemetrexed and Platinum Chemotherapy as First-Line Therapy for Nonsquamous Non-Small Cell Lung Cancer 2021-02-03 12:30
Elekta's MOSAIQ and Versa HD earn top honors in 2021 Best in KLAS: Software and Services Report 2021-02-03 00:30
Kira Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial for P014, a Bifunctional Biologic Medicine 2021-02-02 20:00
Ascentage Pharma Released Preclinical Results of MDM2-p53 Inhibitor APG-115 in an Oral Presentation at WCLC 2020, Demonstrating Therapeutic Potential in STK11-Mutant Non-Small Cell Lung Cancer 2021-02-02 17:24
Globally unique MRI Guarantee: The highest MRI safety with hearing implants from MED-EL 2021-02-02 15:00
Inmagene launched U.S. subsidiary; Dr. Jean-Louis Saillot joined the company. 2021-02-02 14:48
Nippon Express (Thailand) Obtains GDP Certification for Domestic Transport Services 2021-02-02 14:00
Kintor's GT20029 IND for PROTAC AR Degrader Was Accepted by NMPA 2021-02-02 12:11
CF PharmTech and Chengdu Shangyi Launch the "Home-Based Recovery Program for Discharged Covid-19 Patients" and Announce Today's Global Release of the "R Plus Health" Free App 2021-02-02 09:00
DW Healthcare Partners Invests in Parnell 2021-02-02 08:23
Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet 2021-02-01 14:00
Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate 2021-02-01 14:00
Antengene Announces Collaboration with WuXi Biologics and WuXi STA to Advance Antibody-Drug Conjugate Candidate into Clinical-stage 2021-02-01 08:09
DWHP Announces Expiration And Final Results Of Its Cash Tender Offer For All Outstanding Ordinary Shares Of Parnell Pharmaceuticals Holdings Ltd. 2021-01-30 07:38
Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been Granted Fast Track Designation by the U.S. FDA 2021-01-29 22:53
1 260 261 262 263 264 412